EF
ITOS

Empowered Funds’s iTeos Therapeutics ITOS Stock Holding History

Empowered Funds’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-69,072
Closed -$530K – 1706
2024
Q4 		$530K Buy
69,072
+3,305
+5% +$28.4K 0.01% 1162
2024
Q3 		$671K Buy
65,767
+3,350
+5% +$51.1K 0.01% 1009
2024
Q2 		$926K Buy
62,417
+4,500
+8% +$64.5K 0.02% 885
2024
Q1 		$790K Sell
57,917
-63,313
-52% -$690K 0.01% 963
2023
Q4 		$1.33M Buy
121,230
+10,920
+10% +$108K 0.03% 665
2023
Q3 		$1.21M Buy
110,310
+9,006
+9% +$115K 0.04% 603
2023
Q2 		$1.34M Buy
+101,304
New +$1.44M 0.05% 529

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Empowered Funds's ITOS Position: Q1 2025 in Review

Empowered Funds sold out of iTeos Therapeutics (ITOS) in Q1 2025, closing a stake of 69,072 shares — an estimated $530K sold.

Empowered Funds first reported a position in ITOS in Q2 2023 and held it in 7 quarters. The position peaked at $1.34M in Q2 2023. 131 funds tracked by Wall St. Rank hold ITOS as of Q1 2025.

  • Empowered Funds reported no remaining iTeos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Empowered Funds sold 69,072 iTeos Therapeutics shares in Q1 2025, an estimated $530K.
  • Empowered Funds first reported a position in iTeos Therapeutics in Q2 2023 and held it in 7 quarters.
  • Empowered Funds's iTeos Therapeutics position peaked at $1.34M in Q2 2023.
  • 131 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2025.

Based on Empowered Funds's 13F filing for Q1 2025, filed 16 May 2025.